# How Glucose Sensors Check Their Own Reliability for Insulin Pumps > This patent describes a system that automatically checks how trustworthy a continuous glucose sensor's readings are and then adjusts how an insulin pump delivers medicine based on that trust level. - **Patent:** US 9282925 - **Original title:** Systems and methods for replacing signal artifacts in a glucose sensor data stream - **Owner:** Dexcom - **Granted:** 2016 - **Status:** Active - **Times cited:** 10 - **Field:** consumer_electronics, software, biotech, medical_devices, telecommunications ## What it does The patent details a system (Claim 14) and method (Claim 1) for a continuous glucose sensor (CGS) to assess its own data quality. An "electronics unit" receives glucose data from the CGS. A "signal reliability module" on a processor then determines a "level of reliability" for that data. This reliability level is chosen from at least three pre-set options, stored in memory (Claim 1). For example, if the sensor detects "transient non-glucose related signal artifacts" (Claim 8) or a "drift in sensitivity" (Claim 3), it might lower its reliability score. Crucially, this reliability score is then used to "control the administration of a medicament" (Claim 1), such as adjusting insulin delivery from an insulin pump. The system can also prompt a user for a reference glucose value if reliability is low (Claim 13). ## What it does NOT cover - Does not cover systems that only detect noise without using a "level of reliability" selected from "three or more predetermined reliability levels" (Claim 1). - Does not cover systems where the reliability assessment does not directly "control the administration of a medicament" (Claim 1). - Does not cover systems that only filter noise from glucose data without using the reliability level to influence medicament delivery. - Does not cover systems where the reliability is determined by only one or two levels, as "three or more predetermined reliability levels" are specified (Claim 1). - Does not cover systems that only display reliability to a user without also controlling medicament administration. ## The clever bit The novelty lies in not just detecting signal issues, but in assigning a specific, multi-level "reliability score" to the sensor data and then directly using that score to control medicament administration. This moves beyond simple error flags to a more nuanced, automated decision-making process for drug delivery. ## Real-world examples 1. Automated insulin delivery systems 2. Artificial pancreas systems 3. Dexcom G6/G7 continuous glucose monitoring systems 4. Medtronic MiniMed 780G insulin pump system ## Why it matters This patent is significant for the development of "closed-loop" or artificial pancreas systems for diabetes management. By enabling a continuous glucose monitor (CGM) to assess its own data quality and automatically adjust insulin delivery, it helps make these systems safer and more effective. It addresses the critical challenge of ensuring reliable sensor data for automated drug delivery. ## Frequently asked questions ### What does How Glucose Sensors Check Their Own Reliability for Insulin Pumps cover? This patent describes a system that automatically checks how trustworthy a continuous glucose sensor's readings are and then adjusts how an insulin pump delivers medicine based on that trust level. ### Who owns patent US 9282925? Dexcom owns this patent, granted in 2016. ### When does this patent expire? This patent is expected to expire on March 25, 2030, when the invention enters the public domain. ### What is patent US 9282925 cited by? This patent has been cited by 10 later patents that build on its ideas. ### What problem does this patent solve? This patent is significant for the development of "closed-loop" or artificial pancreas systems for diabetes management. By enabling a continuous glucose monitor (CGM) to assess its own data quality and automatically adjust insulin delivery, it helps make these systems safer and more effective. It addresses the critical challenge of ensuring reliable sensor data for automated drug delivery. ### What does this patent NOT cover? Does not cover systems that only detect noise without using a "level of reliability" selected from "three or more predetermined reliability levels" (Claim 1). **Full plain-English explainer:** https://patentbrief.org/patent/us/9282925/systems-and-methods-for-replacing-signal-artifacts-in-a-glucose-sensor-data-stre **Original patent:** https://patents.google.com/patent/US9282925 --- _Source: PatentBrief — https://patentbrief.org. Patent facts are from public records; the plain-English explanation is PatentBrief's._ ## Related patents Semantically similar inventions in the PatentBrief corpus: - [How a Sensor Checks Itself for Accuracy Using Other Body Data](https://patentbrief.org/patent/us/20230263439/systems-and-methods-for-multi-analyte-sensing) — This patent describes a smart system that uses additional body measurements or relationships between different body chemicals to figure out if an analyte sensor, like a glucose monitor, is giving wrong readings and then fixes it or tells you to replace it. - [How Devices Precisely Track Glucose Across Body Compartments](https://patentbrief.org/patent/us/9854998/method-andor-system-for-multicompartment-analyte-monitoring) — This patent describes a method for accurately estimating a person's blood glucose by accounting for the natural time delay in how glucose moves between different body fluids, like blood and the fluid around cells, to better control insulin pumps. - [How Continuous Glucose Monitors Estimate Blood Sugar Levels Accurately](https://patentbrief.org/patent/us/8882665/method-andor-system-for-multicompartment-analyte-monitoring-8882665) — This patent describes a method for accurately estimating blood glucose levels by accounting for the natural delay in glucose moving between interstitial fluid and blood, using sensor data and its rate of change. - [How a Computer System Automatically Adjusts Blood Sugar in Real-Time](https://patentbrief.org/patent/us/8956321/computerized-system-for-blood-chemistry-monitoring) — This patent describes a computerized system that continuously monitors a patient's blood glucose and automatically adjusts insulin and dextrose delivery to keep blood sugar levels stable, especially for critically ill patients. - [How Medical Monitors Adapt Oxygen Alarms to Reduce False Alerts](https://patentbrief.org/patent/us/RE47218/tysabri-dosing) — This patent describes an adaptive alarm system for medical patient monitors that dynamically adjusts oxygen saturation thresholds based on recent patient data, aiming to reduce unnecessary alerts.